Back to Search Start Over

The 24-Hour Movement Paradigm: An integrated approach to the measurement and promotion of daily activity in cancer clinical trials.

Authors :
Shirazipour CH
Raines C
Diniz MA
Salvy SJ
Haile RW
Freedland SJ
Asher A
Tomasone JR
Gresham G
Source :
Contemporary clinical trials communications [Contemp Clin Trials Commun] 2023 Jan 31; Vol. 32, pp. 101081. Date of Electronic Publication: 2023 Jan 31 (Print Publication: 2023).
Publication Year :
2023

Abstract

Increased physical activity (PA), improved sleep, and decreased sedentary behavior (SB) are essential components of supportive care for cancer survivors. However, researchers and health care professionals have achieved limited success in improving these behaviors among cancer survivors. One potential reasoning is that, over the past two decades, guidelines for promoting and measuring PA, sleep, and SB have been largely siloed. With greater understanding of these three behaviors, health behavior researchers have recently developed a new paradigm: the 24-Hour movement approach. This approach considers PA, SB, and sleep as movement behaviors along a continuum that represent low through vigorous intensity activity. Together these three behaviors form the sum of an individual's movement across a 24-hour day. While this paradigm has been studied in the general population, its usage is still limited in cancer populations. Here, we seek to highlight (a) the potential benefits of this new paradigm for clinical trial design in oncology; (b) how this approach can allow for greater integration of wearable technology as a means of assessing and monitoring patient health outside the clinical setting, improving patient autonomy through self-monitoring of movement behavior. Ultimately, implementation of the 24-Hour movement paradigm will allow health behavior research in oncology to better promote and assess critical health behaviors to support the long-term well-being for cancer patients and survivors.<br />Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (© 2023 The Authors.)

Details

Language :
English
ISSN :
2451-8654
Volume :
32
Database :
MEDLINE
Journal :
Contemporary clinical trials communications
Publication Type :
Academic Journal
Accession number :
36875555
Full Text :
https://doi.org/10.1016/j.conctc.2023.101081